3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
9
OTHER_GOV
2
NETWORK
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Nasopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Neoplasms, Germ Cell and Embryonal
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Cancer
1
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Interventions
Cisplatin
2
avelumab
1
Paclitaxel
1
Ifosfamide
1
Everolimus
1
Disulfiram
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms, Germ Cell and Embryonal
×
Cisplatin
×
Clear all
NCT07121322
2025-08-13
DACT-GCT
National Cancer Institute, Slovakia
Phase 2
Recruiting
33 enrolled
NCT02414685
2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2
Completed
19 enrolled